As the official journal of the American Association for the Study of Liver Diseases, Hepatology is privileged to publish selected acknowledgments of major contributions made to the field of liver disease, such as those of Hyman J. Zimmerman. ## "Lives of great men all remind us We can make our li
Introduction to the revised American Association for the Study of Liver Diseases position paper on acute liver failure 2011
โ Scribed by William M. Lee; R. Todd Stravitz; Anne M. Larson
- Publisher
- John Wiley and Sons
- Year
- 2012
- Tongue
- English
- Weight
- 716 KB
- Volume
- 55
- Category
- Article
- ISSN
- 0270-9139
No coin nor oath required. For personal study only.
โฆ Synopsis
Preamble
The present version of the American Association for the Study of Liver Diseases (AASLD) Position Paper represents a thorough overhaul from the previous version of 2005. In addition to two new additional authors, the revision includes updated expert opinion regarding (1) etiologies and diagnosis, (2) therapies and intensive care management, and (3) prognosis and transplantation. Because acute liver failure (ALF) is an orphan disease, large clinical trials are impossible and much of its management is based on clinical experience only. Nonetheless, there are certain issues that continue to recur in this setting as well as growing consensus (amidst innovation) regarding how to maximize the ALF patient's chance of recovery. The changes in ALF management are not global in nature, but are more consistent with incremental experience and improvements in diagnosis and intensive care unit management.
๐ SIMILAR VOLUMES
This guideline has been approved by the American Association for the Study of Liver Diseases (AASLD) and represents the position of the association. ## Preamble These recommendations provide a data-supported approach to establishing guidelines. They are based on the following: (1) a formal review
This report summarizes a recent meeting cosponsored by the American Society of Transplant Physicians and the American Association for the Study of Liver Diseases to formulate minimal criteria by which patients with severe liver disease will be placed on the waiting list for liver transplantation. Th
We read with great interest the practice guidelines for the diagnosis and management of autoimmune hepatitis recently issued by the American Association for the Study of Liver Diseases (AASLD). 1 In particular, we appreciate the new definition of biochemical remission, which now requires not only no